13 filings
6-K
PBM
Psyence Biomedical Ltd. Warrant
20 Sep 24
Share Purchase and Sale Agreement
5:00pm
6-K
PBM
Psyence Biomedical Ltd. Warrant
13 Sep 24
Psyence Biomedical Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq
5:00pm
6-K
PBM
Psyence Biomedical Ltd. Warrant
5 Sep 24
Current report (foreign)
4:31pm
6-K
PBM
Psyence Biomedical Ltd. Warrant
30 Aug 24
Current report (foreign)
4:06pm
6-K
PBM
Psyence Biomedical Ltd. Warrant
20 Aug 24
Current report (foreign)
6:01am
6-K
nlj9 zizbppbw
31 Jul 24
Common Stock Purchase Agreement
4:11pm
6-K
pkdiocye0
24 Jul 24
Current report (foreign)
4:35pm
6-K
cqoaykvhxr9m4r6lx
23 Jul 24
Current report (foreign)
4:05pm
6-K
k83xmkj
5 Jul 24
Psyence Biomedical Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
6:03am
6-K
pe6hu419jl
20 Jun 24
Current report (foreign)
4:10pm
6-K
qlv5pe n3
6 Jun 24
Current report (foreign)
8:00am
6-K
ysf0l11zpmmj8
15 Mar 24
Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares
5:10pm
6-K
kmqmrs y4gdm8xv
12 Mar 24
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
5:25pm
- Prev
- 1
- Next